Gameto

Bee Cave, TX · Founded 2020 · Medtech · Private

Improved egg freezing and IVF technologies using advanced cryopreservation and egg maturation methods

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated · gametogen.com

Sector
Medtech
Headquarters
Bee Cave, TX
Founded
2020
Latest Form D
$44M, Aug 2025
Total capital
$117M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$117M
4 Form D · last Aug 2025
14 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
23 pending · first 2023
Rank in peer group#370 of 1112

Capital timeline

2022202320242025FEDERAL ↑EQUITY ↓Cumulative $117M1st Form D$20M2nd Form D$9.6M3rd Form D$43M4th Form D$44M
2022202320242025FEDERAL ↑EQUITY ↓Cumulative $117M3rd Form D$43M4th Form D$44M

Latest events

  • Private capital raisedForm D · SEC · 4th filing$44M
  • Private capital raisedForm D · SEC · 3rd filing$43M
  • Private capital raisedForm D · SEC · 2nd filing$9.6M
  • Private capital raisedForm D · SEC · 1st filing$20M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#370 · top 33%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Dina RadenkovicResearcherExecutive Officer, DirectorLinked by 1 patent
  • Dusan PerovicDirectorNamed in SEC Form D filings
  • Dylan MorrisDirectorNamed in SEC Form D filings
  • Jonathan HostensDirectorNamed in SEC Form D filings
  • Kristina SimmonsDirectorNamed in SEC Form D filings
  • Martin VarsavskyDirectorNamed in SEC Form D filings
Show all 7 people
  • Maryanna SaenkoDirectorNamed in SEC Form D filings

What it has protected

USPTO · 3 granted of 26
Show all 26 patent records
  • Implant For Ovarian Decline And Methods Of Manufacturing An Implant For Ovarian DeclineOct 13, 2026 · US 12,758,684Granted
  • Compositions And Methods For Inducing Oocyte MaturationMay 28, 2026 · Application 19181929Pending
  • Production And Applications Of Ovarian And Uterine OrganoidsMar 26, 2026 · Application 19109690Pending
  • Compositions And Methods For Inducing Oocyte MaturationDec 4, 2025 · Application 18875590Pending
  • Platform And Method For Determining Critical Transcription Factors (tf) For Tf-based Human Induced Pluripotent Stem Cell (hipsc) DifferentiationFeb 13, 2025 · Application 18443541Pending
  • Platform And Method For Engineering A Human Organoid Replica For Reproductive ScreeningJan 30, 2025 · Application 18424348Pending
  • Apparatus And Method For Oocyte Rescue In Vitro Post StimulationDec 19, 2024 · Application 18419006Pending
  • Apparatus And Method For Inducing Human Oocyte Maturation In VitroMay 23, 2024 · Application 18371694Pending
  • Implant For Ovarian Decline And Methods Of Manufacturing An Implant For Ovarian DeclineFeb 15, 2024 · Application 18224687Pending
  • Apparatus And Method For Inducing Human Oocyte Maturation In VitroOct 31, 2023 · US 11,802,268Granted
  • Implant For Ovarian Decline And Methods Of Manufacturing An Implant For Ovarian DeclineSep 5, 2023 · US 11,744,920Granted
  • Platform And Method For Determining Critical Transcription Factors (tf) For Tf-based Human Induced Pluripotent Stem Cell (hipsc) DifferentiationMay 11, 2023 · Application 17981881Pending
  • Identification, Interrogation, And Induction Of Critical Transcription Factor For In Vitro Germ Cell DifferentiationApplication 63277292Pending
  • Compositions And Methods For Improving Ovarian FunctionApplication 19102710Pending
  • Production And Applications Of Ovarian And Uterine OrganoidsApplication PCTUS2023032312Pending
  • Methods And Compositions For Producing Ovarian Support Cell Co-cultureApplication PCTUS2025026115Pending
  • Methods And Compositions For Producing Ovarian Support Cell Co-cultureApplication 63778244Pending
  • Compositions And Methods For Producing Ovarian Support CellsApplication 63709073Pending
  • Methods And Compositions For Producing Ovarian Support Cell Co-cultureApplication 63638204Pending
  • Methods And Compositions For Producing Ovarian Support Cell Co-cultureApplication PCTUS2024021368Pending
  • Compositions And Methods For Producing Ovarian Support CellsApplication PCTUS2025051662Pending
  • Compositions And Methods For Improving Ovarian FunctionApplication PCTUS2023030167Pending
  • Compositions And Methods For Inducing Oocyte MaturationApplication PCTUS2023026012Pending
  • Methods And Compositions For Producing Ovarian Support Cell Co-cultureApplication 63492210Pending
  • Platform And Method For Engineering A Human Organoid Replica For Reproductive ScreeningApplication 17941423Pending
  • Apparatus And Method For Oocyte Rescue In Vitro Post StimulationApplication 17846845Pending
  • CARDIO-THERANOSTICS LLCSimilar federal contract value in Medtech · null in contracts
  • VECTOR SURGICAL, LLCSimilar federal contract value in Medtech · null in contracts
  • FEMASYS INCSimilar federal contract value in Medtech · null in contracts
  • ATTOGENE CORPORATIONSimilar federal contract value in Medtech · null in contracts
  • TMRW Life Sciences, Inc.Similar federal contract value in Medtech · null in contracts
  • CICERODX, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .